357 Results (Page 10 of 15)
South Africa Markets Research Reports
South Africa Interactive Wound Dressing Market Analysis
South Africa interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.
South Africa Interferons Market Analysis
South Africa interferons market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. It is anticipated that the development of novel drug delivery systems and the use of interferons in combination therapy will drive the market for interferons. The key players in this market are Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, Synairgen, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics.
South Africa Interstitial Cystitis Drugs Market Analysis
South Africa interstitial cystitis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of interstitial cystitis and public knowledge of the ailment can be attributed for the market expansion. The key players in this market are Alvogen (CVC Capital Partners), Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd., Accord Healthcare, Avet Pharmaceuticals Inc. (Heritage Pharmaceuticals Inc.), Lannett, Viatris Inc. (Pfizer Inc.), Reckitt Benckiser Group PLC, VistaPharm, Inc, Aurobindo Pharma, Prestige Consumer Healthcare Inc.
South Africa Intravenous Solutions Market Analysis
South Africa intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.
South Africa Irritable Bowel Syndrome Drugs Market Analysis
South Africa irritable bowel syndrome drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased illness awareness, the expected timely availability of recently approved drugs, an enhanced payment system, and rising IBS prevalence are the main market drivers for IBS-D pharmaceuticals. The key players in this market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.
South Africa Isoflavones Market Analysis
South Africa isoflavones drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is primarily driven by three factors: the growing elderly population, technological developments in the production of isoflavones, and the rising prevalence of cancer and other chronic disorders. The major key players in this market are Cargill, BASF, DSM, Shanghai Freemen, and ADM. Other key players include Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Avestia Pharma, NutraScience Labs, Tradichem S.L., Nutra Green Biotechnology.
South Africa Kidney Cancer Drugs Market Analysis
South Africa kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.
South Africa Knee Cartilage Repair Market Analysis
South Africa knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.
South Africa Anemia Therapeutics Market Analysis
The South Africa Anemia Therapeutics Market is anticipated to experience a growth from $96 Mn in 2022 to $211 Mn by 2030, with a CAGR of 10.33% during the forecast period of 2022-2030. The expansion of the therapeutics market is driven by the elevated prevalence of anemia in women and children, stemming from factors like chronic diseases, nutritional deficits, and government efforts aimed at fortification, supplementation, and improved accessibility to cost-effective pharmaceuticals. The South Africa Anemia Therapeutics Market encompasses various players across different segments, including Sanofi, AstraZeneca, Pfizer, AbbVie, Pharmacosmos, AMAG Pharmaceuticals, Roche, Novartis, Adcock Ingram, Aspen Pharmacare etc, among various others.
South Africa Dermatological Therapeutics Market Analysis
South Africa Dermatological Therapeutics Market is at around $0.27 Bn in 2022 and is projected to reach $0.52 Bn in 2030, exhibiting a CAGR of 9.83% during the forecast period. The market is expanding due to a rise in the elderly population, increased awareness and education, and a surge in dermatological conditions. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.
South Africa Alopecia (Hair Loss) Therapeutics Market Analysis
The South Africa Alopecia (Hair Loss) Therapeutics Market was valued at US $53 Mn in 2022, and is predicted to grow at (CAGR) of 8.73% from 2023 to 2030, to US $104 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), emerging treatment alternatives in response to demand, and others. The industry is primarily dominated by players such as Pfizer, Merck, Eli Lilly, Johnson & Johnson, Bayer, and Lutronic, among others.
South Africa Allergy Therapeutics Market Analysis
South Africa Allergy Therapeutics Market was valued at $151 Mn in 2022 and is estimated to reach $272 Mn in 2030, exhibiting a CAGR of 7.63% during the forecast period. The demand for allergy treatment medications is rising due to the rise in allergic conditions and related medical conditions. GlaxoSmithKline, Sanofi, Novartis, AstraZeneca, Bayer, Aspen Pharmacare, Adcock Ingram, Lupin Ltd., Cipla Medpro, and Pfizer are the top leading pharmaceutical companies that are presently operating in the market.
South Africa Alcohol Addiction Therapeutics Market Analysis
The South Africa Alcohol Addiction Therapeutics Market is valued at around $5 Mn in 2022 and is projected to reach $8 Mn by 2030, exhibiting a CAGR of 7.53% during the forecast period. Major drivers in the South Africa Alcohol Addiction Therapeutics Market include increased research into newer treatment options, demand for comprehensive therapy that includes non-pharmaceutical interventions, and a rising incidence of alcohol use driven by high rates, economic challenges, and mental health disorders. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in South Africa are Alkermes, Aspen Healthcare, Pfizer, Teva Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), EthyPharm, Merck & Co., Otsuka, etc., among others.
South Africa Nutritional Supplements Market Analysis
By 2030, it is anticipated that the South Africa Nutritional and Supplements market will reach a value of $xx Bn from $2.48 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. The market for nutrition and supplements in South Africa is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The South Africa nutrition and supplements market in South Africa is segmented by Type, Product, application, and Distribution Channel.
South Africa Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The South Africa Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $21 Mn in 2022, and is predicted to grow at (CAGR) of 9.03% from 2023 to 2030, to US $43 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, rising investment, increased government initiatives, and other factors. The industry is primarily dominated by players such as Spectrum Pharmaceutical, AbbVie, Pfizer, AstraZeneca, Novartis and other players
South Africa Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The South Africa Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $7 Mn in 2022, and is predicted to grow at (CAGR) of 7.03% from 2023 to 2030, to US $12 Mn by 2030. The key drivers of this industry include the several government initiatives and policies to support rare diseases and increased awareness among the population regarding the condition. The industry is primarily dominated by players such as Otsuka Pharmaceutical, AceLink Therapeutics, Palladio Biosciences, Reata Pharmaceutica, Xortx, Regulus Therapeutics, and Galapagos NV among others
South Africa Age-Related Macular Degeneration Therapeutics Market Analysis
The South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $70 Mn in 2022 and is predicted to grow at a CAGR of 10.13% from 2023 to 2030, to US $152 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, expanding healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
South Africa Addiction Therapeutics Market Analysis
South Africa addiction therapeutics market was valued at $66 Mn in 2022 and is estimated to reach $123 Mn in 2030, exhibiting a CAGR of 8.13% during the forecast period. Public awareness has improved as a result of the anti-drug campaigns and encouraging government measures, and this has significantly expanded the addiction therapeutics market. Some of the leading companies in the market are Aspen Pharmacare, Adcock Ingram, Mylan Pharmaceuticals, Teva Pharmaceuticals, AbbVie, Reckitt Benckiser, Sun Pharma Industries, Cipla, Alkermes and Lupin Pharmaceuticals
South Africa Adult Malignant Glioma Therapeutics Market Analysis
The South Africa Adult Glioma Therapeutics Market is valued at around $14 Mn in 2022 and is projected to reach $31 Mn by 2030, exhibiting a CAGR of 10.13% during the forecast period. There is potential for higher demand for therapies as glioma diagnosis and treatment become more accessible in South Africa due to advancements in glioblastoma awareness, changing demographics, growing healthcare infrastructure, and changing treatment choices. Key players in the South Africa Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Aspen, Spectrum Pharmaceuticals, Adcock Ingram, Pharmatrans etc among others
South Africa Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the South Africa Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Africa Virtual Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
South Africa Pharmaceutical Market Analysis
This report presents a strategic analysis of the South African pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South African pharmaceutical Market, offering unmatched value, accuracy, and expert insights.
South Africa Pain Management Devices Market Analysis
This report presents a strategic analysis of the South Africa Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Africa Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
South Africa Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the South Africa Liver Disease Therapeutics market will reach a value of $257 Mn from $150 Mn in 2022, growing at a CAGR of 6.9 % during 2022-30. Liver Disease Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare, Adcock Ingram, and Pharma Dynamics. The Liver Disease Therapeutics market in South Africa is segmented into different types of disease and different therapy types. Some of the major factors affecting the South Africa Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
South Africa ENT Devices Market Analysis
South Africa ENT Devices Market is projected to grow from $150 Mn in 2022 to $260 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the South Africa ENT devices market include SONIC Innovations, Medtronic South Africa, and ENRAF Nonius.
South Africa Diabetes Therapeutics Market Analysis
South African diabetes therapeutics market is expected to grow from $935 Mn in 2022 to $2,145 Mn in 2030 with a CAGR of 10.93% for the forecasted year 2022-30. Several preventive measures taken by the government to control diabetes and other programs aiming to cover the treatment costs in South Africa are responsible for the expansion of the market. The South African diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Biovac, iNova Pharmaceuticals, and Eli Lilly are the major players in the South African diabetes therapeutics market.